Apresa

Quick links to important sections

Apresa

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Apresa

Property Description
Active ingredient Amlodipine (besilate salt)
Form Tablet, Oral Solution, Suspension
Pharmacological class Calcium Channel Blocker (CCB)
Common purpose Antihypertensive and Antianginal Agent
Origin Synthetic, Small Molecule

What Kind of Medicine is Apresa and What is its Composition?

Apresa is a long-acting, prescription-only medication whose core component is the active ingredient Amlodipine, a synthetic small molecule. The compound is typically supplied as Amlodipine besilate to ensure its stability and reliable absorption. Apresa is officially classified as a Calcium Channel Blocker (CCB), specifically belonging to the dihydropyridine pharmacological subclass. This compound is a single active ingredient product, designed for prolonged therapeutic impact on the cardiovascular system.

Drug Form, Type, and Unique Characteristics

Apresa functions as an Antihypertensive and Antianginal Agent, reducing blood pressure and managing certain types of chest pain. It is prepared in various pharmaceutical preparations, including the oral tablet and the liquid oral solution or suspension, with the prescribed route of administration being oral. A key characteristic that differentiates Amlodipine is its extensive half-life, which can range significantly. This prolonged systemic presence supports its use in continuous, once-daily management, making it an established standard in treatment protocols. This longer action is the primary reason why the medicine only needs to be taken once daily to maintain a consistent therapeutic effect.

What is the General Purpose of Apresa?

The general purpose of Apresa is to assist the heart and circulatory system by relaxing blood vessels and easing the strain on the heart muscle. Its basic action involves selectively blocking the necessary entry of calcium ions into the arterial smooth muscle cells, causing direct peripheral arterial vasodilation—the widening of arteries. This physiological action reduces the total peripheral vascular resistance in the body. The resulting decrease in resistance achieves the general benefit of lowering blood pressure and ensuring a more consistent supply of oxygen-rich blood to the heart muscle, which is a crucial factor for patients experiencing chronic stable angina.

Regulatory References

  1. NIH MedlinePlus

What side effects are possible with Apresa?

Possible Side Effects and Safety Information

The regulatory documentation for Apresa (Amlodipine) outlines a safety profile categorized by frequency and physiological system-organ class. The adverse reactions are classified according to official standards, ranging from Very Common to Very Rare.

The most frequently reported effect is oedema (fluid retention or swelling), particularly of the ankles, which is classified as a Very Common reaction in Summary of Product Characteristics (SmPC) documents. Effects classified as Common typically relate to the nervous and vascular systems, including headache, dizziness, somnolence, flushing, and palpitations. Gastrointestinal effects such as nausea and abdominal pain, as well as general fatigue, are also common.

Regulatory labeling notes that certain effects, such as headache and dizziness, may be more pronounced especially at the beginning of treatment.

Serious Adverse Reactions and Safety Constraints

Official documents highlight the potential for certain serious events, classified as Very Rare. These include reactions involving the cardiac system, such as myocardial infarction (heart attack) and arrhythmia, and the hepatobiliary system, such as hepatitis and jaundice. Severe allergic reactions, including angioedema and Stevens Johnson Syndrome, are also documented in the most infrequent categories.

Specific safety considerations are noted for special populations. Caution is formally advised when administering the medicine to older adults and individuals with hepatic impairment, as clearance may be reduced, potentially increasing systemic exposure. The medicine is contraindicated in those with known hypersensitivity to Amlodipine or other dihydropyridine derivatives.

Overdose and Emergency Response

Overdose and when to seek help

Overdose Scope

Overdosage of Apresa (Amlodipine) is primarily characterized by excessive peripheral vasodilation leading to marked and prolonged systemic hypotension. Other documented clinical signs may include reflex tachycardia and a decreased level of consciousness. The most severe, life-threatening outcomes are profound hypotension and vascular collapse (shock), which carry a risk of fatal outcome. Patients must seek immediate medical attention if overdose is suspected. Due to the active ingredient's long elimination half-life (30–50 hours), continuous hospital observation is required for an extended period. Population-specific notes indicate that patients with hepatic impairment and elderly patients may experience prolonged effects due to reduced clearance.


Overdose Classifications

The severity is classified by regulatory agencies as potentially severe and life-threatening. No specific antidote is known for Apresa overdose. Management is centered on symptomatic and supportive treatment to maintain cardiovascular function.


Resulting Overdose Structure

Official overdose statements:

  • Overdosage is associated with excessive peripheral vasodilation resulting in marked systemic hypotension.
  • Severe hypotension can progress to vascular collapse and carries the risk of a fatal outcome.
  • Management is symptomatic and supportive treatment to maintain cardiovascular function.
  • Continuous monitoring of blood pressure and cardiac function is required for an extended period.
  • Gastric lavage or activated charcoal may be considered if administered shortly after ingestion.
  • Vasopressors may be necessary if hypotension is refractory to initial fluid replacement.

Therapeutic Uses of Apresa

What Apresa Treats: Main Uses and Benefits

Apresa is generally considered relevant for addressing conditions marked by increased physiological stress on the cardiovascular system and may be part of symptomatic management that supports functional stability. The therapeutic profile includes the management of high blood pressure and specific types of chest discomfort.

This medication is commonly used to help with conditions like essential hypertension, chronic stable angina, and vasospastic angina. It is relevant across therapeutic domains where additional symptomatic support is needed for patients of varying ages, including pediatric patients (age 6 to 17) for high blood pressure and older adults.

“Its use contributes to improved comfort during periods of heightened symptoms related to vascular strain.”

Its use provides supportive relief when symptoms interfere with routine activities, and may assist with maintaining functional stability because it is commonly used to help with symptom management across conditions associated with increased physiological stress. This medication is specifically applied in addressing symptom clusters that interfere with daily functioning, offering supportive relief when symptoms become temporarily overwhelming.


Quick Fact: Relief for Elevated Blood Pressure and Chest Discomfort Apresa is applied in addressing persistently elevated systolic and diastolic blood pressure readings and helps ease the overall symptom load related to recurrent or episodic manifestations of angina.

Eligibility and Restrictions for Use

Apresa (Amlodipine) is a prescription-only medicine whose use is strictly governed by regulatory eligibility rules that define who can be treated and who is formally prohibited from using the drug.

Populations and Conditions Prohibited from Use (Contraindications)

Official regulatory information states that Apresa is contraindicated (must not be used) in patients with the following conditions:

  • Hypersensitivity: Known sensitivity to Amlodipine, its components, or other dihydropyridine derivatives.
  • Cardiovascular Instability: Patients with severe hypotension, shock (including cardiogenic shock), or obstruction of the outflow tract of the left ventricle (e.g., high-grade aortic stenosis).
  • Post-Myocardial Infarction: Patients with haemodynamically unstable heart failure after an acute myocardial infarction.

Age-Related Eligibility Status

Population Group Regulatory Status Note
Adults (18+ years) Approved for all labeled uses. Normal dosage regimens are used, with care advised for dose increases in the elderly.
Children (6–17 years) Approved for hypertension only. Use in excess of 5 mg daily has not been studied.
Children (Under 6 years) Safety and efficacy not established. Data are insufficient for this age group.

Conditional Use and Restrictions

Use of Apresa requires caution in patients with specific conditions:

  • Hepatic Impairment: Use is cautioned in patients with impaired liver function due to prolonged clearance, and slow titration is advised in severe hepatic impairment.
  • Heart Failure: Caution is required in patients with congestive heart failure (NYHA Class III and IV).
  • Pregnancy and Lactation: Safety during pregnancy is not established; use is restricted to cases where the benefit is critical. The medicine is excreted in human milk, and a decision to discontinue the medicine or breastfeeding must be made.

What should I know about interactions with other medicines?

Apresa (amlodipine) has documented interaction patterns with other medicines, specific foods, and herbal products, as defined in government regulatory labeling. These interactions are categorized based on their mechanism, primarily involving changes in systemic drug exposure or additive physiological effects.

Documented Interaction Patterns

Interacting Substance/Class Regulatory-Stated Outcome/Restriction
CYP3A Inhibitors (e.g., Clarithromycin, Azole Antifungals) Increases systemic exposure to Amlodipine, which may require monitoring for symptoms of hypotension.
CYP3A Inducers (e.g., Rifampin, St. John's Wort) Expected to decrease Amlodipine plasma concentrations (reduced exposure), potentially lessening the clinical effect.
Simvastatin (Antilipidemic Agent) Co-administration significantly increases Simvastatin exposure. The regulatory label mandates a maximum daily dose limit of 20 mg for Simvastatin.
Immunosuppressants (e.g., Cyclosporine, Tacrolimus) Amlodipine may increase the systemic exposure of these agents, requiring frequent monitoring of their blood levels.
Other Antihypertensive Agents (e.g., Beta-blockers, Diuretics, Sildenafil) Results in additive antihypertensive effects, requiring monitoring for increased blood pressure lowering.
Dantrolene (Infusion) Co-administration is formally stated to be avoided due to the risk of hyperkalaemia.
Grapefruit or Grapefruit Juice Not recommended as consumption may increase Amlodipine bioavailability in certain individuals.

Population-Specific Interaction Notes

The systemic clearance of Amlodipine is decreased in patients with severe hepatic impairment. This reduced clearance results in a higher systemic exposure to the drug, a condition which may magnify the clinical significance of documented interaction effects with other agents.

Mechanism of Action

Targeting Voltage-Gated L-Type Calcium Channels

The primary mechanism of Apresa involves the targeted blockade of L-Type Calcium Channels (CaV1.2) primarily in arterial smooth muscle. By functioning as a selective inhibitor, the active compound prevents the transmembrane influx of essential extracellular calcium ions (Ca^2+) into the cell. This inhibition effectively interrupts the excitation-contraction coupling pathway, which is required for the muscle fiber to shorten.

Mechanism-Driven Arterial Vasodilation

This molecular interference initiates a cascade leading directly to the relaxation of the vascular smooth muscle cells and causing peripheral arterial vasodilation (widening of the arteries). This physiological widening reduces the total resistance the heart encounters when ejecting blood, resulting in a reduction of the pressure exerted on the systemic circulation.

Kinetics and Coronary Vascular Modulation

The molecule's binding exhibits slow association and dissociation kinetics, resulting in a gradual onset of effect that minimizes rapid changes in vascular tone and limits compensatory physiological reflexes. Furthermore, the vasodilation mechanism extends to the coronary arteries, which results in the modulation of vascular resistance within the coronary circulation.

Dosage and Administration Information

How to Use Apresa

Apresa (amlodipine) is used via oral administration and is intended for continuous, long-term use to manage chronic conditions. The medicine is primarily supplied as a tablet, although official oral liquid forms (solution or suspension) are also available in specific strengths.

Administration and Scheduling Principles

The standard procedure is to take Apresa once daily, at approximately the same time each day, a schedule enabled by the drug's prolonged action. The medicine's absorption is not significantly affected by food intake; therefore, it may be taken with or without meals, according to the patient's routine.

Official Dosing and Adjustments

Official prescribing information establishes defined dosing rules that govern the use of Apresa in specific patient groups. These guidelines set the initial starting dose, the acceptable maintenance range, and the absolute maximum daily intake.

Patient Population Starting Dose (Once Daily) Maximum Recommended Dose (Once Daily)
Adults (Hypertension & Angina) 5 mg 10 mg
Older Adults 2.5 mg 10 mg
Pediatric (6–17 yrs, Hypertension) 2.5 mg 5 mg

For adults, the typical maintenance range is between 2.5 mg and 10 mg. A lower initial dose of 2.5 mg is specifically recommended for older adults or those with impaired liver function to account for potential differences in drug processing. If a dose is missed, the next dose should be taken at the usual scheduled time; the missed dose should not be taken later in the day.

Recent Clinical Evidence

Research evidence / Overview of Studies for Apresa

Evidence for Use in High Blood Pressure (Hypertension)

Research into Apresa for high blood pressure primarily involves large-scale Randomized Controlled Trials (RCTs) and meta-analyses. These studies were used in research exploring how blood pressure readings—specifically systolic and diastolic measurements—change in the observed populations. Studies also monitored the occurrence of major cardiovascular events, such as stroke or heart attack, over extended follow-up periods.

Researchers reported the measured changes in blood pressure during the observed study periods. The trials involving pediatric patients (ages 6–17) reported short-term changes in blood pressure readings, which were then compared against the control group. The full long-term impact on cardiovascular health in this specific younger population is not fully established by current research.


Evidence for Use in Chronic Stable Angina and Vasospastic Angina

Research has examined Apresa in clinical trials for chronic stable angina and smaller studies for vasospastic angina. These trials explored how symptoms change over time, specifically focusing on patient-reported outcomes describing perceived discomfort and functional limitations.

Findings describe patterns observed in the recorded frequency of angina episodes reported by study participants. For vasospastic angina—a condition characterized by fluctuating or episodic manifestations—the research describes patterns related to short-term symptom changes. However, studies exploring the long-term impact on functional stability for vasospastic angina are generally limited, and the evidence for stable angina primarily focuses on outcomes related to physical discomfort, with long-term monitoring of event patterns often being secondary measures.


Long-Term Studies and Durability of Response

A significant part of the research has focused on monitoring the effects of Apresa over extended periods, often several years, particularly in adults with high blood pressure. These studies monitored outcomes related to systemic or functional imbalance and sought to determine if the measured changes in blood pressure and cardiovascular event patterns persist over time. Follow-up durations were limited in some of the smaller trials, meaning long-term effects are not fully established across all indications and patient profiles.

Key Studies & References

  1. Highlights of Prescribing Information (Amlodipine) – U.S. Food and Drug Administration (FDA) Drug Label
  2. Amlodipine: Uses, Side Effects & Dosage - Drugs.com (Based on FDA data)
  3. A Pilot Study Exploring Efficacy and Safety of Amlodipine in the Stented Angina Patients (NCT01120327) - ClinicalTrials.gov

Frequently Asked Questions (FAQ)

Common questions about Apresa (FAQ)


Q: How quickly should I expect Apresa to start working?

A: Apresa is a long-acting medicine designed for a gradual onset of action. While the process begins immediately, official product information suggests that the full blood pressure-lowering effect often takes about 7 to 14 days of continuous daily use to be observed in clinical trials.


Q: What is the typical duration of effect for Apresa?

A: Apresa has a prolonged presence in the body, or a long half-life, which enables it to be effective throughout the day. This characteristic allows the blood pressure and anti-angina effects to be maintained for at least 24 hours, supporting its use as a once-daily medicine.


Q: What are the most commonly reported side effects of Apresa?

A: Regulatory documents list oedema (swelling, especially of the ankles) as the most frequently reported side effect. Other common effects reported in clinical trials include headache, dizziness, and general fatigue.


Q: Can I take pain relievers like ibuprofen with Apresa?

A: Regulatory documents describe a potential interaction between Apresa and certain pain relievers, such as nonsteroidal anti-inflammatory drugs (NSAIDs). This combination may reduce the expected blood pressure-lowering effect.


Q: Is Apresa safe for older adults?

A: Apresa is approved for use in older adults. A lower initial starting dose is often used in this population, as noted in the product information, to account for potential differences in drug processing.


Q: What happens if I miss a dose of Apresa?

A: Regulatory guidance states that a missed dose should not be taken later that day. Instead, the next dose is typically taken at the usual scheduled time.


Q: Are there any signs that Apresa is not working for me?

A: The medicine is prescribed to lower blood pressure and/or reduce the frequency of angina episodes. Therefore, if blood pressure targets are not met or angina symptoms do not change, the intended therapeutic effect may not be fully realized.


Q: What are the long-term side effects of taking Apresa?

A: The long-term safety profile is derived from extended studies and post-marketing reports, which document the continued occurrence of known common and rare effects.


Q: Can I stop taking Apresa once my blood pressure is under control?

A: Apresa is indicated for the chronic, long-term management of conditions like hypertension and angina. Abruptly discontinuing the medicine carries a potential risk for the return of high blood pressure or a worsening of angina symptoms.


Q: Is it normal for my face to feel flushed after taking Apresa?

A: Flushing—a feeling of heat or redness in the face or body—is listed in regulatory documents as a common side effect of Apresa. Flushing is a reported occurrence documented in clinical trials.


Q: Does Apresa cause weight gain or loss?

A: Changes in weight (both gain and loss) have been reported, although they are not classified among the most common adverse effects. Weight gain is noted in relation to the drug's profile, and it can be associated with fluid retention (oedema), which is a common side effect.


Q: Can Apresa affect my sleep?

A: Regulatory reports on the medicine have indicated that some central nervous system side effects can occur. These include reports of both somnolence (drowsiness) and insomnia (difficulty sleeping).


Q: Are there any specific foods I should avoid while taking Apresa?

A: Official regulatory information advises against consuming grapefruit or grapefruit juice. This is because these products may increase the amount of Apresa absorbed into the bloodstream in some individuals.


Q: Is Apresa associated with joint pain or muscle aches?

A: Reports from post-marketing experience have noted instances of joint pain (arthralgia) and muscle cramps. These effects are documented in association with the medicine.


Q: Can Apresa cause a rash or skin reactions?

A: Skin reactions, including general rash and itching (pruritus), have been reported in regulatory documents. In extremely rare cases, more serious skin conditions have also been documented.


Q: Is the tiredness I feel from Apresa normal?

A: Fatigue and somnolence (drowsiness) are officially listed as common adverse reactions associated with Apresa. These effects are reported, particularly when treatment is initiated.


Q: Does Apresa cause any issues with vision?

A: Visual disturbances have been noted in post-marketing reports. These have included blurred vision and the perception of double vision (diplopia).


Q: Is there a specific time of day best for taking Apresa?

A: Apresa can be taken at any time of the day, with or without food. However, to maintain a consistent therapeutic effect, regulatory guidance suggests taking it at approximately the same time each day.


Q: Are there any known withdrawal effects from stopping Apresa?

A: Official documentation does not typically detail a specific withdrawal syndrome. However, abrupt discontinuation may be associated with the return of high blood pressure or a potential worsening of angina symptoms.


Q: Are there any lifestyle changes that make Apresa work better?

A: Regulatory documents indicate that Apresa is often part of a comprehensive plan for managing cardiovascular risk. Official information suggests that this comprehensive approach can include supportive factors such as dietary modifications, increased physical activity, and smoking cessation.

How should Apresa be stored and disposed of?

How to Store and Dispose of Apresa (Amlodipine Besilate)

Official regulatory guidelines require Apresa tablets to be stored at Controlled Room Temperature, which is maintained between 20 C and 25 C (68 F and 77 F). The medication must be kept in its original, tightly closed container and protected from excess heat, light, and moisture. Storage in environments such as the bathroom is advised against.

To ensure safety, the product must be kept out of sight and reach of children.

For disposal of unused or expired tablets, the preferred method is an authorized drug take-back program. If this is unavailable, the medicine should be mixed with an undesirable substance (such as dirt) in a sealed container and placed in the household trash. Apresa is not on the list of medicines recommended for flushing down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Apresa found in:

A-Z Index: